Among the 187 patients, 149 were estrogen receptor (ER)‐positive, based on immunohistochemical analysis of the primary tumor, highlighting the prevalence of ER‐positive disease in breast cancer with bone metastasis. This evidence concerns the gene ESR1 and breast carcinoma.